| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/14/1997 | US5593980 Antiarthritic agents for administering |
| 01/14/1997 | US5593978 Growth promoting composition for fish and method of using the same |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/14/1997 | US5593975 Adenosine derivatives having A2 agonist activity |
| 01/14/1997 | US5593971 Alone or in combinaation with angiotensin converting enzyme inhibitor |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593823 Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens |
| 01/14/1997 | US5593697 Single dose vaccination system |
| 01/14/1997 | US5593696 Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
| 01/14/1997 | US5593695 Morphine therapy |
| 01/14/1997 | US5593686 Pharmaceutical compositions |
| 01/14/1997 | US5593685 Ranitidine compositions |
| 01/14/1997 | US5593684 Transdermal and transmucosal administration of nicotine at controlled levels in blood |
| 01/14/1997 | US5593681 Glycine anhydride dimethylol as a biocide and preservative |
| 01/14/1997 | US5593671 Method of attenuating lung capillary leak in a mammal |
| 01/14/1997 | US5593665 Pharmaceutical compositions |
| 01/14/1997 | US5593664 Polyamides, polyureas |
| 01/14/1997 | US5593661 Of lidocaine in a 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane propellant |
| 01/14/1997 | CA2111096C Thiazolidinedione hypoglycemic agents |
| 01/14/1997 | CA2082952C Color modified melanins and methods for their preparation and use |
| 01/14/1997 | CA2070366C Prophylactic/therapeutic composition for swine pleuropneumonia |
| 01/14/1997 | CA2056814C Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity |
| 01/14/1997 | CA2045680C High ibuprofen content granulations |
| 01/14/1997 | CA1338845C Thiophene 2-carboxamide derivatives and their use as pharmaceuticals |
| 01/14/1997 | CA1338844C Thiophene carboxamine derivatives and their use as pharmaceuticals |
| 01/14/1997 | CA1338842C Cephem compound and a process for preparation thereof |
| 01/12/1997 | CA2180085A1 Narcotic antagonist |
| 01/09/1997 | WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000891A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | WO1997000884A1 Meiosis regulating compounds |
| 01/09/1997 | WO1997000882A1 Therapeutic compounds |
| 01/09/1997 | WO1997000880A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 01/09/1997 | WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 01/09/1997 | WO1997000868A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 01/09/1997 | WO1997000864A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | WO1997000863A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | WO1997000860A1 Cb2 receptor agonist compounds |
| 01/09/1997 | WO1997000855A1 Herpes ribonucleotide reductase inhibitors |
| 01/09/1997 | WO1997000853A1 Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 01/09/1997 | WO1997000692A1 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 01/09/1997 | WO1997000689A1 Antiviral agents |
| 01/09/1997 | WO1997000688A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/09/1997 | WO1997000687A1 Immunopotentiator |
| 01/09/1997 | WO1997000684A1 Cladinose for use as a drug, and pharmaceutical compositions containing same |
| 01/09/1997 | WO1997000682A1 Compressed dry-granulation desogestrel tablets |
| 01/09/1997 | WO1997000681A1 Pharmaceutical composition containing lamotrigine |
| 01/09/1997 | WO1997000680A1 Use of n-cyclohexyl benzamides for treating bowel disorders |
| 01/09/1997 | WO1997000679A1 Biflavanoids and derivatives thereof as antiviral agents |
| 01/09/1997 | WO1997000678A1 Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions |
| 01/09/1997 | WO1997000677A1 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 01/09/1997 | WO1997000676A1 Antimicrobial and anti-inflammatory compounds |
| 01/09/1997 | WO1997000675A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | WO1997000670A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 01/09/1997 | WO1997000668A1 Stable hydroalcoholic compositions |
| 01/09/1997 | WO1997000667A1 Stable hydroalcoholic compositions |
| 01/09/1997 | WO1997000623A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 01/09/1997 | WO1997000621A1 Use of hydroxy acid or a product containing the same and a product made thereof |
| 01/09/1997 | WO1996040040A3 Thrombin receptor homolog |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996038165A3 Endoparasiticidal agents |
| 01/09/1997 | WO1996037214A3 Compositions of interleukin and pyrimidine nucleosides |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | DE19626616A1 Verfahren zur Herstellung von 1,1-Dioxo-cephem-4-ketonen A process for the preparation of 1,1-dioxo-cephem-4-ketones |
| 01/09/1997 | DE19524765A1 Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds |
| 01/09/1997 | CA2225462A1 Analgesic use of n-l-.alpha.-aspartyl-l-phenylalanine 1-methyl ester |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225406A1 Methods for treatment and prevention of diabetes |
| 01/09/1997 | CA2225379A1 Cb2 receptor agonist compounds |
| 01/09/1997 | CA2225341A1 Biflavanoids and derivatives thereof as antiviral agents |
| 01/09/1997 | CA2225336A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 01/09/1997 | CA2225277A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 01/09/1997 | CA2225247A1 Therapeutic compounds |
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 01/09/1997 | CA2224875A1 Use of hydroxy acid or a product containing the same and a product made thereof |
| 01/09/1997 | CA2224866A1 Meiosis regulating compounds |
| 01/09/1997 | CA2224798A1 Stable hydroalcoholic compositions |
| 01/09/1997 | CA2224702A1 Stable hydroalcoholic compositions |
| 01/09/1997 | CA2222266A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 01/09/1997 | CA2221863A1 New therapeutic applications of n-cyclohexylbenzamides |
| 01/09/1997 | CA2220925A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | CA2220529A1 Aromatic compounds and pharmaceutical compositions containing them |
| 01/09/1997 | CA2219739A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/08/1997 | EP0752424A1 Nicotinic acid derivative and herbicide |
| 01/08/1997 | EP0752421A1 Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists |
| 01/08/1997 | EP0752419A2 Process for the preparation of N-substituted 4-ketoproline derivatives |
| 01/08/1997 | EP0752249A2 Use of an angiotensin II antagonist and a benzofurane derivative having antiarithmic activity for the manufacture of a medicament for the treatment of cardiovascular disorders |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752247A1 Compositionss containing corticosteroids and chlorinated phenols for the treatment of atopic eczema |
| 01/08/1997 | EP0752246A2 Kappa opiate agonists for inflammatory gut diseases |
| 01/08/1997 | EP0752243A2 Container filled with infusion liquids |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752002A1 Inhibition of arterial smooth muscle cell proliferation |
| 01/08/1997 | EP0752000A1 Packaging-deficient lentiviruses |
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751948A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |